ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Halozyme Therapeutics Incorporated

Halozyme Therapeutics Incorporated (HALO)

38.97
0.26
(0.67%)
Closed April 23 4:00PM
38.97
0.00
( 0.00% )
Pre Market: 4:00AM

Halozyme Therapeutics Incorporated Financial Summary

The current HALO market cap is 4.94B. The company's latest EPS is USD 2.2203 and P/E is 17.55.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 208.98M181.5M162.14M221.04M216.03M
Operating Income 63.19M74.51M53.8M94.46M88.28M
Net Income 61.63M57.7M39.62M74.75M81.84M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 195.99M267.59M443.31M660.12M829.25M
Operating Income -67.61M144.26M275.9M267.53M337.57M
Net Income -72.24M129.09M402.71M202.13M281.59M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.86B1.84B1.7B1.81B1.89B
Total Liabilities 1.77B1.67B1.63B1.66B1.64B
Total Equity 96.99M169.8M65.85M151.03M249.18M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 565.87M579.92M1.1B1.84B1.73B
Total Liabilities 474.11M428.88M907.48M1.67B1.65B
Total Equity 91.77M151.05M196.95M169.8M83.81M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 157.66M240.11M86.96M153.81M286.22M
Investing -485.26M-487.01M-60.16M-5.17M-88.62M
Financing 356.04M362.37M-164.61M-162.17M-158.07M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -85.42M55.45M299.44M240.11M388.57M
Investing -5.55M78.35M-406.29M-487.01M-96.91M
Financing 153.22M-106.28M77.87M362.37M-407.99M
Market Cap 4.94B
Price to Earnings Ratio 17.55
Price to Sales Ratio 5.96
Price to Cash Ratio 41.76
Price to Book Ratio 58.97
Dividend Yield -

Share Statistics

Shares Outstanding 126.82M
Average Volume (1 week) 773.68k
Average Volume (1 Month) 876.74k
52 Week Change 13.71%
52 Week High 45.00
52 Week Low 29.85
Spread (Intraday) 13.49 (25.71%)

Company Info

Company Name Halozyme Therapeutics Incorporated
Address 1209 orange street
wilmington, delaware 19801
Website https://www.halozyme.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock